GetTopicDetailResponse(id=ad00e32097, topicName=FDA突破性療法指定, introduction=FDA突破性療法指定, content=null, image=null, comments=1, allHits=837, url=https://h5.medsci.cn/topic?id=7320, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=102428, tagList=[TagDto(tagId=102428, tagName=FDA突破性療法指定)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1704966, encodeId=b3ad1e049668d, content=<a href='/topic/show?id=ad00e32097' target=_blank style='color:#2F92EE;'>#FDA突破性療法指定#</a>, objectTitle=Achillion的D因子抑制劑Danicopan治療陣發(fā)性夜間血紅蛋白尿，獲得FDA突破性療法指定, objectType=article, longId=180107, objectId=1e3218010eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e3218010eb7, replyNumber=0, likeNumber=88, createdTime=2020-06-18, rootId=0, userName=zhenjiu133, userId=590f30907809, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e3218010eb7, moduleTitle=Achillion的D因子抑制劑Danicopan治療陣發(fā)性夜間血紅蛋白尿，獲得FDA突破性療法指定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1e3218010eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
